APA (7th ed.) Citation

Y, X., N, L., G, P., X, H., X, C., & X, Z. The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Xin, Liu N, Peng G, Huang X, Cao X, and Zhou X. The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors. Dove Medical Press.

MLA (9th ed.) Citation

Y, Xin, et al. The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors. Dove Medical Press.